Bioqual, Inc. (BIOQ)
OTCMKTS · Delayed Price · Currency is USD
35.20
0.00 (0.00%)
At close: May 7, 2026

Bioqual Income Statement

Millions USD. Fiscal year is Jun - May.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 May '25 May '24 May '23 May '22 May '21
42.3548.8758.5962.6666.1557.68
Revenue Growth (YoY)
-13.57%-16.59%-6.50%-5.27%14.68%24.43%
Cost of Revenue
34.2739.7346.5550.0649.239.82
Gross Profit
8.079.1412.0512.616.9517.86
Selling, General & Admin
10.3611.0312.0611.510.429.31
Operating Expenses
10.3611.0312.0611.510.429.31
Operating Income
-2.29-1.9-0.021.16.538.56
Interest & Investment Income
0.60.610.480.0300
Other Non Operating Income (Expenses)
0.1500.0200.040.06
EBT Excluding Unusual Items
-1.54-1.290.481.136.588.62
Pretax Income
-1.54-1.290.481.136.588.62
Income Tax Expense
-0.31-0.24-0.010.31.322.29
Net Income
-1.24-1.050.480.845.266.33
Net Income to Common
-1.24-1.050.480.845.266.33
Net Income Growth
---42.14%-84.12%-16.85%49.54%
Shares Outstanding (Basic)
111111
Shares Outstanding (Diluted)
111111
Shares Change (YoY)
----0.00%0.04%0.01%
EPS (Basic)
-1.38-1.170.540.935.887.08
EPS (Diluted)
-1.38-1.170.540.935.887.08
EPS Growth
---41.94%-84.18%-16.91%49.61%
Free Cash Flow
5.942.718.765.99-4.57-2.26
Free Cash Flow Per Share
6.643.039.806.69-5.11-2.53
Dividend Per Share
0.5000.5000.5000.5001.0001.250
Dividend Growth
----50.00%-20.00%13.64%
Gross Margin
19.06%18.70%20.56%20.11%25.62%30.97%
Operating Margin
-5.40%-3.88%-0.03%1.76%9.88%14.83%
Profit Margin
-2.92%-2.15%0.83%1.33%7.95%10.97%
Free Cash Flow Margin
14.02%5.54%14.95%9.55%-6.91%-3.92%
EBITDA
-0.040.472.543.388.259.92
EBITDA Margin
-0.10%0.97%4.33%5.39%12.46%17.19%
D&A For EBITDA
2.252.372.562.281.711.36
EBIT
-2.29-1.9-0.021.16.538.56
EBIT Margin
-5.40%-3.88%-0.03%1.76%9.88%14.83%
Effective Tax Rate
---26.27%20.01%26.57%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.